Introduction
The function of type I interferons (IFNs) in the regulation of the innate immune response is clearly established [1] [2] [3] . More recently, the importance of the type I IFN family (several α and one β subtypes)
in the generation of a T cell-mediated adaptive immunity has emerged 4, 5 . The fact that IFNβ is produced by dentritic cells (DCs) upon Toll-Like Receptor (TLR) stimulation and that it can act as a differentiation and maturing factor on DCs have led to the concept that it is a cytokine linking innate and adaptive immunity 6 . Type I IFNs are however never produced alone: TLR-3 or TLR-4 stimulation of human monocyte-derived DCs by their respective ligands, induce the production of IFNβ and IFNsλ as well 7 .
The IFNλ family was recently described [8] [9] [10] . It possesses 3 members: λ1, λ2 and λ3, also known as IL-29, IL28A and IL-28B, respectively. IFNsλ exhibit several common features with type I IFNs since they are capable of establishing an antiviral state in sensitive cell lines, probably because they share with type I IFNs an intracellular signaling pathway which drives the expression of a common set of IFN-stimulated genes (ISGs) 11, 12 . However, IFNsλ signaling is initiated through a membrane receptor system distinct from that of type I IFNs, composed of a unique IFNLR1 subunit and the IL10R2 chain, also part of the IL-10, IL-22 and IL-26 receptors 13 . The different receptor usage of type I IFNs and IFNsλ could give rise to unique signaling pathways in addition to recruiting Stat1 and Stat2, both activated by type I and λ IFNs through the Tyk2 and Jak1 kinases. Another important difference between type I and λ IFNs is the regulation of their receptor expression. Whereas IFNAR1 and IFNAR2, the two chains of the type I IFN receptor, and IL10R2, the second chain of the IFNλ receptor are ubiquitously expressed, IFNLR1 expression is cell type dependent. Indeed, a limited variety of tissues is responsive to IFNsλ 13, 14 and we show here that IFNLR1, while not
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From expressed in monocytes, is upregulated during the DC differentiation program initiated in human monocytes by GM-CSF and IL-4. Immature DCs (iDCs) are thus fully responsive to IFNλ.
DCs play several key functions in immunity. iDCs reside in peripheral tissues where they capture antigens. Signals such as TLRs stimulation or type I IFNs acting through a paracrine or autocrine manner, induce DCs to mature in that they acquire the ability to migrate to lymphoid organs and to present antigens to naive T cells through MHC class I and II. Depending of their maturation state which correlates with the level of MHCs and costimulatory molecule expression, DCs can drive an expansion and proliferation of either effector or regulatory T cells 15, 16 .
Experiments presented in this paper were undertaken to define the role of IFNλ in the maturation of human monocytes-derived DC. We show that IFNλ promotes the generation of partially mature DCs which display a tolerogenic phenotype: IFNλ-matured DCs express high levels of MHC I and II but low levels of costimulatory molecules and acquire the ability to migrate into lymph nodes when intravenously injected into immunodeficient mice. In allogeneic cultures, IFNλ-matured DCs specifically induce an IL-2-dependent proliferation of a CD4 + , CD25 + , Foxp3 + T cell population with contact-dependent suppressive activity on T cell proliferation. Thus, in contrast to type I IFNs that render iDCs potent inducers of Th1 cells 3, 5, 6 , IFNλ drives iDCs into a maturation stage that promotes regulatory T cell expansion. membranes (Nunc). For MLR experiments using neutralizing anti-IL-2 Abs, cells were cultured 9 days at 1/10 DC/T initial ratio in 96-well plates as described above or in 24 well-plates at 2×10 6 cells/ml for real time PCR analysis. Cells were cultured in DC medium in the presence of anti-IL-2 Abs or normal rabbit control IgG (references 500-P22 and 500-P00 from PreproTech) at 250 ng/ml final concentration.
IL-12 assays
iDCs were treated with IFNs, LPS or medium for 48 hrs or used as stimulating cells in MLR culture after 24h of maturation during 8 days at 1/10 DC/T ratio. Human IL-12p70 release in culture supernatants was determined by ELISA following the manufacturer's instructions (Becton Dickinson OptEIA™ Kit).
RT-PCRs
Quantitative RT-PCR using Light Cycler (Roche) for GAPDH and 2'5' oligo adenylate synthetase were performed as previously described 17 . Sequences of primers used for Foxp3 and IFNLR1 amplifications were as follows: Foxp3 forward: 5'CCAGGACAGGCCACATTCA 3', Foxp3
CCGGAAACAAGACCCTATT 3', IFNLR1 reverse: 5' CAGGTGGGCTTAGAGAACTT 3'. The specificity of the primer pairs were validated by DNA sequencing of the PCR products All data are expressed as a ratio to the GAPDH level. The standard errors of the ratios were calculated using Student's t test (95% confidence limits).
In vivo migratory assays
iDCs were treated either with IFNs, LPS or medium for 24 hrs, extensively washed and intravenously injected (3×10 6 cells/mouse) into SCID/Bg immunodeficient mice. PBS injections 8 were used as negative controls. Recipient mice were sacrificed 8 hrs or 24 hrs post adoptive transfer and organs were collected under sterile conditions. DNA extractions were done using DNeasy Tissue KitAll (Qiagen). The presence of human alu repetitive sequence was analysed by PCR on 7 ng of DNA using alu Sp primer set: forward: 5'ACCCCGTCTCTACTAAAAAT 3', reverse: 5' AGTTTCGCTCTTGTTGC 3'. Amplifications were done for 30 cycles with an annealing temperature of 60°C using Platinium Taq DNA Polymerase (Invitrogen) and analysed on ethidium bromide containing 2% agarose gel. Quantitative PCR on the Light Cycler (Roche) were done using the alu Sb8 primer set as described 18 . Data were standardized against the amount of murine DNA as quantified using a primer set detecting the intronless murine IFNα4 gene. Forward: 5' CCTGTGTGATGCAGGAACC 3', reverse: 5' ATGAGTGGTGGTTGCAGGC 3'. The standard errors of the ratios were calculated using Student's t test (95% confidence limits).
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Results

Induction of IFNLR1 expression and IFNλ responsiveness during DCs differentiation
Unlike the ubiquitously expressed type I IFNs receptor, expression of the IFNsλ receptor is cell type specific and it is thought that IFNLR1 is not expressed in leukocytes 13 . Accordingly, the transcript encoding IFNLR1 was hardly detectable by RT-PCR in freshly isolated human CD14 + monocytes.
However, IFNLR1 mRNA was detectable in both circulating blood DCs and in DCs generated in vitro from monocytes treated with GM-CSF and IL-4 ( Figure 1Ai ). IFNLR1 mRNA was also expressed by DCs and macrophages generated by culturing monocytes in the presence of GM-CSF and IFNβ or GM-CSF alone, respectively ( Figure 1Aii ). IFNLR1 mRNA level was gradually increased during DC differentiation, reaching its maximum level when monocytes were close to their full state of DC differentiation ( Figure 1B ). IL10R2, the second chain of the IFNλ receptor was constitutively expressed by both monocytes and DCs at any maturation states (data not shown). DCs, but not monocytes were consequently responsive to IFNλ as shown in figure 1C for the induction of 2'5' oligo adenylate synthetase gene, a classical ISG whose expression is a signature of both type I and λ IFNs early response. Monocytes were resistant to IFNλ and accordingly, we observed that IFNλ cannot substitute IL-4, as opposed to IFNβ which could drive differentiation of monocytes into DCs ( Figure 1D ) 5 .
IFNλ-treated DCs efficiently migrate into lymphoid compartments in vivo
We evaluated the activity of IFNλ on DCs maturation. 
IFNλ treated DCs display a partially matured phenotype
The cell surface expression levels of MHC class I, class II and some co-stimulatory molecules were evaluated by FACS in IFNλ-treated DCs and compared on the one hand to iDCs and on the other hand to LPS or IFNβ-matured DCs (Figure. We then tested the ability of the IFNλ-treated DCs to induce T cell proliferation in MLR culture.
iDCs and DCs treated with IFNλ, IFNβ or LPS were extensively washed and incubated with allogeneic T lymphocytes during 7 to 9 days. Figure 3B shows that the ability of IFNλ-treated DCs to induce T lymphocyte proliferation was lower than LPS or IFNβ-matured DCs.
Full maturation of DCs is associated with loss of their ability to take up antigens. Using a FITClabelled dextran uptake assay, we could show that in this respect, IFNλ-treated DCs are immature since they retained their phagocytic ability ( Figure 4A ). Together, these data indicate that IFNλ induces only a subset of DCs maturation markers, which include CCR7 expression, migratory ability and MHC I and II cell surface expression. For all other maturation markers tested, IFNλ-treated DCs remain mainly immature. Accordingly, IFNλ-treated DCs are not very potent to induce T cell proliferation in allogeneic reaction. They have a partially matured phenotype which is reminiscent of the phenotype of tolerogenic DCs 15, 16 .
For 20 . Accordingly, in the absence of a secondary signal such as CD40 ligation or TLR stimulation, IL12p70 was barely detectable in IFNλ-treated DC culture medium, whereas it was massively released by LPS-matured DCs and at lower level by IFNβ-treated cells. In allogeneic reaction, IL12p70 was released at high level by LPS-matured DCs and IFNβ-treated cells, but was maintained at low level in culture supernatant of MLR stimulated by iDCs and IFNλ-treated DCs ( Figure 4B ). In order to establish whether IFNλ-treated DCs could specifically induce the proliferation of the CD4 + CD25 + T cell subpopulation, freshly purified CD4 + T cells were separated for their expression of the surface marker CD25 ( Figure 5C ). Figure 5D ). Among all conditions tested in MLR cultures, LPS-matured-DCs were the highest inducers of CD25 -CD4 + T cell proliferation whereas IFNλ-treated DCs were the most efficient stimulating cells for the CD25 + CD4 + T cell proliferation. After 7 days of MLR cultures, the responding CD25 -T cell population was still negative for the expression of the CD25 and the CD25 + population had similar or greater expression of this marker (data not shown).
IFNλ-treated
CD4 + CD25 + T cells generated by IFNλ-treated DCs are naturally occurring regulatory T cells
If T cells proliferation was inhibited by up to 60% when the CD4 + CD25 + T cells were added at 1/2 ratio to responding T cells. At 1/5 ratio we observed around 30% of inhibition compared to the control MLR reaction and around 10% of inhibition when added at 1/20 ratio. In contrast, by using a permeable filter system that allowed secreted molecules to diffuse within the culture reaction but Taken together, these data indicate that IFNλ-treated DCs are capable through a mechanism that involves IL-2, to specifically stimulate the proliferation of a regulatory T cell population which meets all criteria of naturally arising regulatory T cells. 25 . In contrast, this report shows that IFNλ has no effect on monocytes, since these DC precursors do not express Recently, the study of a mouse in which a fluorescent reporter was knocked into the Foxp3 locus has allowed to localize Foxp3-expressing cells into lymphoid organs, mainly in peripheral lymph nodes and in the bone marrow 33 . It is thus essential for stimulating DCs to come into close proximity of T cells in lymphoid organs. Our work provides evidence that IFNλ-treated DCs upregulate CCR7 and migrate more efficiently than iDC into the lymph nodes upon i.v. injection into SCID/Bg mice ( Figure 2 ). Thus, it is likely that the unique ability of IFNλ-treated DCs to initiate the proliferation of Since type I IFNs and IFNsλ appear to exert opposite effect on DCs function and given the tolerogenic activity of IFNλ, this latter should be viewed as an element of the cytokine network that acts coordinately to ensure a safe immune response 34 . On the other hand, it cannot be excluded that some physiological or pathological situations may lead to selective IFNλ production. Interestingly, the phenotype of DCs that have ingested apoptotic cells of early phase resembles that of the IFNλ-treated DCs described here 35 . Since removal of dying cells by macrophages and DCs is a natural process that induces T cell tolerance 36 , it would be interesting to monitor the induction of IFNλ during the phagocytosis of apoptotic bodies. Beyong the physiological role of IFNλ, our study also suggests that IFNλ could be instrumental in re-establishing self-tolerance in autoimmune diseases. For
